An update on acute and chronic urticaria for the primary care provider

Postgraduate Medicine

Volumn 121, Issue 1, 2009, Pages 141-151

  Najib, Umer ^a   Sheikh, Javed ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antihistamines; Autoimmune; Basophil; Fc RI autoantibodies; Hives; Mast cell; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CETIRIZINE; CHLORPHENIRAMINE MALEATE; CIMETIDINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; CYPROHEPTADINE; DAPSONE; DESLORATADINE; DIPHENHYDRAMINE; DOXEPIN; FEXOFENADINE; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; HYDROXYZINE; HYDROXYZINE EMBONATE; IMMUNOGLOBULIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LORATADINE; METHOTREXATE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; RANITIDINE; SALAZOSULFAPYRIDINE; THYROXINE; UNINDEXED DRUG; ANTIHISTAMINIC AGENT;

ACUTE URTICARIA; ADD ON THERAPY; ALLERGIC REACTION; ALLERGIC VASCULITIS; ALLERGY TEST; ANAMNESIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; BASOPHIL; BEDTIME DOSAGE; CAUSAL ATTRIBUTION; CHRONIC URTICARIA; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; COLD URTICARIA; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG INDICATION; EMOTION; EVENING DOSAGE; FOOD ALLERGY; HISTAMINE RELEASE; HUMAN; IDIOPATHIC DISEASE; INCREASED APPETITE; INSECT ALLERGY; LOW DRUG DOSE; LYMPHOCYTIC INFILTRATION; MAST CELL; MAST CELL DEGRANULATION; MORBIDITY; OPTIMAL DRUG DOSE; PATHOGENESIS; PATHOPHYSIOLOGY; PENICILLIN ALLERGY; PLASMAPHERESIS; PRIMARY MEDICAL CARE; PROVOCATION TEST; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; SEDATION; SIDE EFFECT; SKIN TEST; SOLAR URTICARIA; THYROID DISEASE; TREATMENT DURATION; TREATMENT RESPONSE; URINE RETENTION; URTICARIA; XEROSTOMIA; ACUTE DISEASE; ADOLESCENT; ADULT; CHRONIC DISEASE; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

ACUTE DISEASE; ADOLESCENT; ADULT; CHRONIC DISEASE; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SEVERITY OF ILLNESS INDEX; URTICARIA; YOUNG ADULT;

EID: 60549094452     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.01.1966     Document Type: Article

References (68)

1. O'Donnell BF, Lawlor F, Simpson J. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136(2):197-201. (Pubitemid 27062719)
2. Kaplan AP. Urticaria angioedema. In: Allergy: Principles and Practice. Adkinson NF Jr, Busse WW, et al; eds. Philadelphia, PA: Mosby; 2003;1537-1558.
3. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angiocdema. A review of 554 patients. Br J Dermatol. 1969;81(8):588-597.
4. Sheikh J. Urticaria. http://emedicine.medscape.com/article/137362- overview.com. Accessed December 18, 2008.
5. Kaplan AP. Urticaria and angioedema. In: Allergy: Principles and Practices. Middleton E, Reed CE, Ellis EF, eds. St. Louis, MO: Mosby-Year Book; 1998;1104-1118.
6. Charlesworth EN. Urticaria and angioedema: a clinical spectrum. Ann Allergy Asthma Immunol. 1996;76(6):484-495. (Pubitemid 126563276)
7. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105(4):664-672. (Pubitemid 30226438)
8. Wong RC, Fairley JA, Ellis CN. Dermographism: a review. J Am Acad Dermatol. 1984;11 (4 pt 1):643-652.
9. Hirschmann JV, Lawlor F, English JS, Louback JB, Winkelmann RK, Greaves MW. Cholinergic urticaria. A clinical and histologic study. Arch Dermatol. 1987;123(4):462-467. (Pubitemid 17050332)
10. Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am. 2004;24(2):183-213. (Pubitemid 38553747)
11. Brodell LA, Beck LA, Saini SS. Pathophysiology of chronic Urticaria. Ann Allergy Asthma Immunol. 2008;100(4):291-297.
12. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW, Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328(22):1599-1604. (Pubitemid 23151920)
13. Jacques P, Lavoie A, Bédard PM, Brunet C, Hébert J. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol. 1992;89(6):1139-1143.
14. Sheikh J. Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they? Curr Opin Allergy Clin Immunol. 2005;5(5):403-407. (Pubitemid 41345307)
15. Goodman DL, McDonnell JT, Nelson HS, Vaughan TR, Weber RW. Chronic urticaria exacerbated by the anti-oxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). J Allergy Clin Immunol. 1990;86(4 pt 1):570-575. (Pubitemid 20372518)
16. Zembowicx A, Mastalerz L, Setkowicz M, et al. Safely of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol. 2003;139(12):1577-1582. (Pubitemid 37523076)
17. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004;114(3):465-474. (Pubitemid 39194914)
18. Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol. 1983;119(8):636-640.
19. Zweiman B, Valenzano M, Atkins PC, Tanus T, Getsy JA. Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol. 1996;98(1):89-98. (Pubitemid 26289390)
20. Sabroe RA, Poon E, Orchard GE, et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Allergy Clin Immunol. 1999;103(3 pt 1):484-493. (Pubitemid 29136303)
21. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002;109(4):694-700. (Pubitemid 34327199)
22. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999;140(3): 446-452. (Pubitemid 29182875)
23. Grattan CE, Wellington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria - a clinical, immunological and histological evaluation. Br J Dermatol. 1986;114(5):583-590. (Pubitemid 16115882)
24. Nguyen L, Sheikh J, Lin CK, et al. Serial basophil histamine release correlates with the clinical course in a patient with autoimmune urticaria. J Allergy Clin Immunol. 2000;104:S40-S41.
25. Grattan CE, Francis DM, Hide M, Greaves MW. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy. 1991;21(6):695-704.
26. Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW. Anti-Fc(epsilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol. 1998;102(4 pt 1):651-658. (Pubitemid 28487943)
27. Ferrer M, Kinét JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. 1998;101(5):672-676. (Pubitemid 28228312)
28. Tong LJ, Balakrishnan G, Kochan JP, Kinét JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99(4):461-465. (Pubitemid 27173082)
29. Asero R, Lorini M, Chong SU, Zuberbier T, Tedeschi A. Assessment of histamine releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy. 2004;34(7):1111-1114. (Pubitemid 38969549)
30. Mari A. Allergy-like asthma and rhinitis: a cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test. Int Arch Allergy Immunol. 2004;133(1):29-39. (Pubitemid 38199397)
31. Guttman-Yassky E, Bergman R, et al. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. J Eur Acad Dermatol Venereol. 2007;21(1):35-39. (Pubitemid 44942321)
32. Vasagar K, Vonakis BM, Gober L, Viksman A, Gibbons SP Jr, Saini SS. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy. 2006;36(6):770-776. (Pubitemid 43972972)
33. Soundararajan S, Kikuchi Y, Joseph K, Kaplan AP. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005;115(4):815-821. (Pubitemid 40460859)
34. Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol. 2001;107(6):1056-1062. (Pubitemid 32523348)
35. Yasnowsky KM, Dreskin SC, Efaw B, et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol. 2006;117(6):1430-1434. (Pubitemid 43795743)
36. Sheikh J. Effect of omalizumab on patients with chronic urticaria: issues with the determination of autoimmune urticaria. with the determination of autoimmune urticaria. Ann Allergy Asthma Immunol. 2008;100(1):88.
37. Saint S, Vasagar K, Huang F, Gibbons S, Vonakis BM. Signaling defects in basophils in chronic urticaria. J Allergy Clin Immunol. 2003;111:S178.
38. Grattan CE, Walpole D, Francis DM, et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basophilia is related to serum histamine releasing activity. Clin Exp Allergy. 1997;27(12):1417-1424. (Pubitemid 28005240)
39. Wanderer AA. Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management. J Allergy Clin Immunol. 1990;85(6):965-981. (Pubitemid 20212450)
40. Amar SM, Dreskin SC. Urticaria. Prim Care. 2008;35(1):141-157.
41. Irinyi B, Széles G, Gyimesi E, et al. Clinical and laboratory examinations in the subgroups of chronic urticaria. Int Arch Allergy Immunol. 2007;144(3):217-225. (Pubitemid 47587608)
42. Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol. 1995;96(6 pt 1):901-905. (Pubitemid 126749715)
43. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84(1):66-71. (Pubitemid 19188993)
44. Joint Task Force on Practice Parameters. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Ann Allergy Asthma Immunol. 2000;85(6 pt 2):521-544.
45. Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol. 2002;88(I):42-51. (Pubitemid 34059649)
46. Dibbern DA Jr. Urticaria: selected highlights and recent advances. Med Clin North Am. 2006;90(1):187-209. (Pubitemid 41682037)
47. Knight TE, Hausen BM. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol. 1994;30(3):423-427. (Pubitemid 24129433)
48. Wong JT, Nagy CS, Krinzman SJ, et al. Rapid oral challenge- desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. 2000;105(5):997-1001. (Pubitemid 30324410)
49. Grattan CL. Aspirin sensitivity and urticaria. Clin Exp Dermatol. 2003;28(2):123-127. (Pubitemid 36459612)
50. Shertzer CL, Lookingbill DP. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol. 1987;123(7):913-916. (Pubitemid 17090481)
51. Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol. 1990;86(6 pt 2):1014-1018.
52. Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother. 1996;30(10):1075-1079. (Pubitemid 26332861)
53. Breneman D, Bronsky EA, Bruce S, et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol. 1995;33(2 pt 1):192-198.
54. Harto A, Sendagorta E, Ledo A. Doxepin in the treatment of chronic urticaria. Dermatologica. 1985;170(2):90-93. (Pubitemid 15164832)
55. Goldsobel AB, Rohr AS, Siegel SC, et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1986;78(5 pt 1):867-873. (Pubitemid 17194639)
56. 2 antihistamine therapy in chronic urticaria. Arch Dermatol. 1981;117:404-407. (Pubitemid 11075329)
57. Harvey RP, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol. 1981;68(4):262-266. (Pubitemid 11027680)
58. Bleehen SS, Thomas SE, Greaves MW, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-center randomized double-blind study. Br J Dermatol. 1987;117(1):81-88. (Pubitemid 17096140)
59. Cook LJ, Shuster S. Lack of effect of cimetidine in chronic-idiopathic urticaria. Acta Derm Venereol. 1983;63(3):265-267.
60. Kaplan AP. Clinical practice: Chronic urticaria and angioedema. N Engl J Med. 2002;346(3):175-179.
61. O'Donnell BF, Barr RM, Black AK, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. 1998;138(1):101-106. (Pubitemid 28077945)
62. Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Plasmapheresis for severe unremitting chronic urticaria. Lancet. 1992;339(8801):1078-1080.
63. Toubi E, Blant A, Kessel A, Golan TD. Low-dose cyclosporin in the treatment of severe chronic idiopathic urticaria. Allergy. 1997;52(3):312-316. (Pubitemid 27166233)
64. Werni R, Schwarz T, Gschnait F. Colchicine treatment of urticarial vasculitis. Dermatoiogica. 1986;172(1):36-40. (Pubitemid 16127744)
65. Ruzicka T, Goerz G. Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. Dermatologica. 1981;162(3):203-205. (Pubitemid 11105846)
66. Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol. 2001;137(1):99-100. (Pubitemid 32096375)
67. Asero R, Tedeschi A, Lorini M. Leukotrience receptor antagonist in chronic urticaria. Allergy. 2001;56(5):456-457. (Pubitemid 32452697)
68. Gober LM, Sterba PM, Eckman JA, Saini SS. Effect of anti-IgE (omalizumab) in chronic idiopathic urticaria (CIU) patients. J Allergy Clin Immunol. 2008;121. Abstract 566.